SOLIGENIX, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
SOLIGENIX, INC. (SNGX) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $6.79 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2019-11-12
- 2019-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $6.79K.
- 2019-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $13.58K.
- 2019-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $20.37K.
- 2018-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $6.79K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2019-09-30 | $6.79K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $13.58K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $20.37K 10-Q · filed 2019-05-14 |
| 2018-09-30 | $6.79K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $20.39K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $30.58K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $37.30K 10-K · filed 2018-03-15 |
| 2017-09-30 | $15.99K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $30.95K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $46.46K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $61.80K 10-K · filed 2017-03-27 |
| 2016-09-30 | $15.38K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $30.96K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $46.38K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $61.80K 10-K · filed 2016-03-24 |
| 2015-09-30 | $81.90K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $81.90K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $81.90K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $173.00K 10-K · filed 2015-03-25 |
| 2014-09-30 | $172.50K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $172.50K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $172.50K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $222.80K 10-K · filed 2014-03-26 |
| 2013-06-30 | $222.80K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $222.80K 10-Q · filed 2013-05-03 |
| 2012-12-31 | $222.80K 10-Q · filed 2013-11-12 |
| 2012-06-30 | $222.80K 10-Q · filed 2012-08-10 |
| 2011-12-31 | $223.20K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |